Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-08

Clinical Trial Update: Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 study evaluating whether adding fluorouracil and/or pegfilgrastim to chemotherapy improves outcomes for women with node-positive breast cancer; the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FLUOROURACIL (Fluorouracil)
  • Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | Conditions: Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING